144 related articles for article (PubMed ID: 28914555)
1. Evaluation of the quality of care of elderly patients with chronic and breakthrough pain treated with opioids: SAND study.
Rodríguez MJ; de la Torre R; Ortega JL; Trinidad JM; Benítez D; Jiménez AJ; Sanz-Yagüe A; Soler B; Torres LM
Curr Med Res Opin; 2018 Apr; 34(4):701-709. PubMed ID: 28914555
[TBL] [Abstract][Full Text] [Related]
2. Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study.
Katz NP; Gajria KL; Shillington AC; Stephenson JJ; Harshaw Q
Postgrad Med; 2017 Jan; 129(1):32-39. PubMed ID: 27846789
[TBL] [Abstract][Full Text] [Related]
3. Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain.
Sperlinga R; Campagna S; Berruti A; Laciura P; Ginosa I; Paoletti S; Giuliano PL; Tucci M; Rosato R; Scagliotti GV; Saini A
Eur J Pain; 2015 Aug; 19(7):881-8. PubMed ID: 25370838
[TBL] [Abstract][Full Text] [Related]
4. Prospective Observational Study of Patient-Controlled Intrathecal Analgesia: Impact on Cancer-Associated Symptoms, Breakthrough Pain Control, and Patient Satisfaction.
Brogan SE; Winter NB; Okifuji A
Reg Anesth Pain Med; 2015; 40(4):369-75. PubMed ID: 25923819
[TBL] [Abstract][Full Text] [Related]
5. Sublingual Fentanyl Tablets for Relief of Breakthrough Pain in Cancer Patients and Association with Quality-of-Life Outcomes.
Guitart J; Vargas MI; De Sanctis V; Folch J; Salazar R; Fuentes J; Coma J; Ferreras J; Moya J; Tomás A; Estivill P; Rodelas F; Jiménez AJ
Clin Drug Investig; 2015 Dec; 35(12):815-22. PubMed ID: 26507617
[TBL] [Abstract][Full Text] [Related]
6. Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS).
Mercadante S; Marchetti P; Cuomo A; Caraceni A; Mediati RD; Mammucari M; Natoli S; Lazzari M; Dauri M; Airoldi M; Azzarello G; Bandera M; Blasi L; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Fusco F; Guardamagna V; Iaffaioli V; Liguori S; Lorusso V; Mameli S; Mattioli R; Mazzei T; Melotti RM; Menardo V; Miotti D; Moroso S; De Santis S; Orsetti R; Papa A; Ricci S; Sabato AF; Scelzi E; Sofia M; Tonini G; Aielli F; Valle A;
Adv Ther; 2017 Jan; 34(1):120-135. PubMed ID: 27873235
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of life.
Portenoy RK; Bruns D; Shoemaker B; Shoemaker SA
J Opioid Manag; 2010; 6(2):109-16. PubMed ID: 20481175
[TBL] [Abstract][Full Text] [Related]
8. National Breakthrough Pain Study: prevalence, characteristics, and associations with health outcomes.
Narayana A; Katz N; Shillington AC; Stephenson JJ; Harshaw Q; Frye CB; Portenoy RK
Pain; 2015 Feb; 156(2):252-259. PubMed ID: 25599446
[TBL] [Abstract][Full Text] [Related]
9. Circadian variation of breakthrough pain in cancer patients.
Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A
Eur J Pain; 2013 Feb; 17(2):264-70. PubMed ID: 22715071
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Breakthrough Pain and Its Impact on Quality of Life in Terminally Ill Cancer Patients.
Gonella S; Sperlinga R; Sciannameo V; Dimonte V; Campagna S
Integr Cancer Ther; 2019; 18():1534735419859095. PubMed ID: 31220961
[No Abstract] [Full Text] [Related]
11. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
[TBL] [Abstract][Full Text] [Related]
12. Fentanyl buccal tablet compared with immediate-release oxycodone for the management of breakthrough pain in opioid-tolerant patients with chronic cancer and noncancer pain: a randomized, double-blind, crossover study followed by a 12-week open-label phase to evaluate patient outcomes.
Webster LR; Slevin KA; Narayana A; Earl CQ; Yang R
Pain Med; 2013 Sep; 14(9):1332-45. PubMed ID: 23855816
[TBL] [Abstract][Full Text] [Related]
13. End-of-dose pain in chronic pain: does it vary with the use of different long-acting opioids?
Zimmermann M; Richarz U
Pain Pract; 2014 Nov; 14(8):757-69. PubMed ID: 24373184
[TBL] [Abstract][Full Text] [Related]
14. Response to Oral Immediate-Release Opioids for Breakthrough Pain in Patients with Advanced Cancer with Adequately Controlled Background Pain.
Azhar A; Kim YJ; Haider A; Hui D; Balankari VR; Epner MC; Park M; Liu DD; Williams J; Frisbee-Hume SE; Allo JA; Bruera E
Oncologist; 2019 Jan; 24(1):125-131. PubMed ID: 30254187
[TBL] [Abstract][Full Text] [Related]
15. Development, validation and psychometric properties of a diagnostic/prognostic tool for breakthrough pain in mixed chronic-pain patients.
Samolsky Dekel BG; Remondini F; Gori A; Vasarri A; Di Nino G; Melotti RM
Clin Neurol Neurosurg; 2016 Feb; 141():23-9. PubMed ID: 26731461
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Patient-Controlled Intravenous Analgesia with Esketamine for Herpes Zoster Associated with Breakthrough Pain.
Tang J; Zhang E; Huang B; Fei Y; Yao M
Pain Physician; 2023 May; 26(3):299-306. PubMed ID: 37192235
[TBL] [Abstract][Full Text] [Related]
17. Fentanyl buccal tablet.
Messina J; Darwish M; Fine PG
Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
[TBL] [Abstract][Full Text] [Related]
18. The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen.
Mercadante S; Prestia G; Casuccio A
Curr Med Res Opin; 2013 Nov; 29(11):1527-32. PubMed ID: 23869428
[TBL] [Abstract][Full Text] [Related]
19. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer.
Hjermstad MJ; Kaasa S; Caraceni A; Loge JH; Pedersen T; Haugen DF; Aass N;
BMJ Support Palliat Care; 2016 Sep; 6(3):344-52. PubMed ID: 27342412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
